Tearsheet
Investment Highlights Market Valuation Price Chart Return vs. Risk About HKPD Interactive Breakdown Better Bets vs. HKPD Latest Trefis Analyses Trade Ideas Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

Hong Kong Pharma Digital Technology (HKPD)

Market Price (10/31/2025): $1.26 | Market Cap: $-
Sector: Consumer Staples | Industry: Drug Retail

Hong Kong Pharma Digital Technology (HKPD)

Market Price (10/31/2025): $1.26
Market Cap: $-
Sector: Consumer Staples
Industry: Drug Retail

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

null
null

Market Valuation & Key Metrics

null

HKPD Stock

null
Factor Drivers of Stock Movement
null

null
null

null
null

null

Return vs. Risk

Price Returns Compared

 202020212022202320242025Total [1]
Returns
HKPD Return------0%
Peers Return-6%1020%-23%-15%-2%-30%380%
S&P 500 Return16%27%-19%24%23%16%110%

Monthly Win Rates [3]
HKPD Win Rate-----38% 
Peers Win Rate18%20%23%22%27%43% 
S&P 500 Win Rate58%75%42%67%75%67% 

Max Drawdowns [4]
HKPD Max Drawdown------ 
Peers Max Drawdown-20%-4%-27%-27%-26%-19% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 

[1] Cumulative total returns since the beginning of 2020
[2] Peers: HKPD, WBA, HITI, PETS, WGRX.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/30/2025 (YTD)

How Low Can It Go

HKPD has limited trading history. Below is the Consumer Staples sector ETF (XLP) in its place.

Unique KeyEventXLPS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-17.5%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven21.2%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven682 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-24.9%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven33.2%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven154 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-16.6%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven19.9%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven404 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-33.4%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven50.2%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven605 days1480 days

Compare to


In The Past

SPDR Select Sector Fund's stock fell -17.5% during the 2022 Inflation Shock from a high on 4/20/2022. A -17.5% loss requires a 21.2% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Hong Kong Pharma Digital Technology (HKPD)

Trade Ideas

Select past ideas related to HKPD. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
IPAR_9302025_Dip_Buyer_FCFYield09302025IPARInterparfumsDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-6.8%-6.8%-6.8%
TAP_9302025_Dip_Buyer_FCFYield09302025TAPMolson Coors BeverageDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-3.8%-3.8%-3.8%
STZ_7312025_Monopoly_xInd_xCD_Getting_Cheaper07312025STZConstellation BrandsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-22.2%-22.2%-22.2%
SJM_6302025_Dip_Buyer_FCFYield06302025SJMJM SmuckerDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		4.1%4.1%0.0%
BF-B_5312025_Dip_Buyer_ValueBuy05312025BF-BBrown-FormanDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		-18.4%-18.4%-22.4%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
IPAR_9302025_Dip_Buyer_FCFYield09302025IPARInterparfumsDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-6.8%-6.8%-6.8%
TAP_9302025_Dip_Buyer_FCFYield09302025TAPMolson Coors BeverageDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-3.8%-3.8%-3.8%
STZ_7312025_Monopoly_xInd_xCD_Getting_Cheaper07312025STZConstellation BrandsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-22.2%-22.2%-22.2%
SJM_6302025_Dip_Buyer_FCFYield06302025SJMJM SmuckerDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		4.1%4.1%0.0%
BF-B_5312025_Dip_Buyer_ValueBuy05312025BF-BBrown-FormanDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		-18.4%-18.4%-22.4%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1PRAXPraxis Precision Medicines279.1%161.2%
2INBXInhibrx Biosciences131.0%409.8%
3PUMPProPetro99.6%16.2%
4DYNDyne Therapeutics88.4%-0.0%
5VICRVicor85.4%89.2%
6CELCCelcuity74.6%503.2%
7GLUEMonte Rosa Therapeutics73.5%87.5%
8NVTSNavitas Semiconductor72.1%251.8%
9LUMNLumen Technologies70.3%94.7%
10BALYBallys63.4%4.1%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1PMIPicard Medical-62.9%5106.3%
2LRNStride-53.8%-35.8%
3FMCFMC-51.0%-66.6%
4FIFiserv-48.3%-68.3%
5NFENew Fortress Energy-43.6%-91.9%
6VGVenture Global-41.7% 
7OGNOrganon-40.2%-55.0%
8VRNSVaronis Systems-39.5%-21.2%
9ITGRInteger-38.5%-52.2%
10LENZLENZ Therapeutics-37.9%5.5%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1INBXInhibrx Biosciences176.8%409.8%
2PUMPProPetro71.2%16.2%
3RNAAvidity Biosciences43.5%139.6%
4DYNDyne Therapeutics42.8%-0.0%
5GCIGannett39.3%3.8%
6FORMFormFactor38.3%34.7%
7MBXMBX Biosciences35.1%18.2%
8BBNXBeta Bionics33.8% 
9GHGuardant Health33.3%202.5%
10LUMNLumen Technologies32.7%94.7%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-75.2%5106.3%
2LRNStride-56.1%-35.8%
3NTLAIntellia Therapeutics-52.6%5.2%
4FMCFMC-48.7%-66.6%
5FIFiserv-47.4%-68.3%
6VRNSVaronis Systems-43.8%-21.2%
7THRYThryv-33.4%-44.8%
8NFENew Fortress Energy-30.5%-91.9%
9AKBAAkebia Therapeutics-29.5%10.5%
10UAMYUnited States Antimony-28.9%371.2%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Hong Kong Pharma Digital Technology

Financials

HKPDWBAHITIPETSWGRXMedian
NameHong Kon.Walgreen.High TidePetMed E.Wellgist. 
Mkt Price1.26-3.062.520.791.89
Mkt Cap-10.40.20.10.00.2
Rev LTM-154,58056822737398
Op Inc LTM--2,87413-0-42-21
FCF LTM-58020-0-610
FCF 3Y Avg--378207-7
CFO LTM-1,577295-517
CFO 3Y Avg-1,2022812-28

Growth & Margins

HKPDWBAHITIPETSWGRXMedian
NameHong Kon.Walgreen.High TidePetMed E.Wellgist. 
Rev Chg LTM-6.2%11.2%-17.2%-6.2%
Rev Chg 3Y Avg-4.8%25.1%-5.2%-4.8%
Rev Chg Q-7.2%13.7%-22.0%17,391.8%10.5%
QoQ Delta Rev Chg LTM-1.7%3.3%-5.4%26.7%2.5%
Op Mgn LTM--1.9%2.3%-0.1%-115.2%-1.0%
Op Mgn 3Y Avg--2.8%1.0%-0.3%--0.3%
QoQ Delta Op Mgn LTM--0.0%0.1%-0.4%13.8%0.0%
CFO/Rev LTM-1.0%5.1%2.1%-13.6%1.5%
CFO/Rev 3Y Avg-0.8%5.4%5.0%-5.0%
FCF/Rev LTM-0.4%3.5%-0.2%-15.6%0.1%
FCF/Rev 3Y Avg--0.3%3.8%3.0%-3.0%

Valuation

HKPDWBAHITIPETSWGRXMedian
NameHong Kon.Walgreen.High TidePetMed E.Wellgist. 
Mkt Cap-10.40.20.10.00.2
P/S-0.10.40.21.30.3
P/EBIT--1.954.1-157.6-1.2-1.5
P/E--1.6-25.4-8.3-1.1-5.0
P/CFO-6.68.511.0-9.77.5
Total Yield--60.8%-3.9%-11.7%-92.8%-36.3%
Dividend Yield-0.0%0.0%0.3%0.0%0.0%
FCF Yield 3Y Avg--2.0%13.4%3.3%-3.3%
D/E-2.80.30.00.50.4
Net D/E-2.70.1-1.00.50.3

Returns

HKPDWBAHITIPETSWGRXMedian
NameHong Kon.Walgreen.High TidePetMed E.Wellgist. 
1M Rtn-14.3%--15.7%0.4%-11.4%-12.8%
3M Rtn16.6%-39.7%-19.2%-9.4%3.6%
6M Rtn5.9%-27.5%-27.6%-81.7%-10.9%
12M Rtn--6.6%-37.5%--15.4%
3Y Rtn--109.6%-87.3%-11.2%
1M Excs Rtn-14.2%--16.9%1.2%-8.5%-11.3%
3M Excs Rtn7.3%-31.6%-31.6%-15.7%-4.2%
6M Excs Rtn-15.9%-5.8%-49.3%-103.4%-32.6%
12M Excs Rtn---14.1%-56.4%--35.3%
3Y Excs Rtn--37.2%-164.3%--63.6%

Financials

$ Mil | FY: 3/31
Period End
Filing Date
Key Financials Quarterly
Total Revenue
Ebitda
Operating Income
Net Income
EPS
Key Financials TTM
Total Revenue TTM
Ebitda TTM
Operating Income TTM
Net Income TTM
Growth Rates Quarterly
Total Revenue Growth
EBITDA Growth
Operating Income Growth
Net Income Growth
Margins Quarterly
EBITDA Margin
Operating Income Margin
Net Income Margin
Cash & Debt
Total Cash
Total Debt
Net Debt / (Cash)
Cash Flows Quarterly
FCF from Operations
Cash Flows TTM
FCF from Operations TTM
Returns to Shareholders Quarterly
Dividends
Share Repurchases
Return on Invested Capital (ROIC) Quarterly
ROIC
Return on Invested Capital (ROIC) TTM
ROIC TTM

Short Interest

Short Interest: As Of Date10152025
Short Interest: Shares Quantity80,879
Short Interest: % Change Since 9302025-54.9%
Average Daily Volume113,280
Days-to-Cover Short Interest1

SEC Filings

Expand for More

Report DateFiling DateFiling
3312025814202520-F 3/31/2025
930202432820256-K 9/30/2024
33120241152025424B4 3/31/2024
33120236282024DRS/A 3/31/2023

Insider Activity

Expand for More

 

External Quote Links


Prefer one of these to Trefis? Tell us why.